Keyword search

Results

All (283)

All (283) (0 to 10 of 283 results)

1. Geographic variation in female breast cancer incidence and mortality in Canada
Articles and reports: 82-003-X202600500001
Description: Previous research has found variability in cancer incidence and cancer-related outcomes according to place of residence. This study examined geographic variability in the incidence and mortality of breast cancer among females in Canada, using data from the 2021 Canadian Cancer Registry (breast cancer incidence) and the Canadian Vital Statistics – Death database (breast cancer mortality). Age-standardized incidence rates (ASIRs) and age-standardized mortality rates (ASMRs) per 100,000 females per year and their rate ratios were calculated, as well as age group-specific and age-standardized stage-specific incidence rates, and examined across provinces and territories, community sizes, and peer groups (i.e., clusters of health regions with similar socioeconomic and demographic characteristics).
Release date: 2026-05-20
2. Enhancing the OncoSim-Breast model using Canadian breast density information
Articles and reports: 82-003-X202600500002
Description: Breast cancer is the most commonly diagnosed cancer among women in Canada. Breast density substantially influences breast cancer risk and mammography performance. However, OncoSim-Breast, a Canadian microsimulation model representing breast cancer control, including cancer onset, screening, and survival, has not previously explicitly accounted for breast density. This study describes the incorporation of density-specific parameters—prevalence, relative risk of breast cancer, and digital mammography performance (sensitivity and specificity)—using data from five Canadian provinces, into the OncoSim-Breast model. Calibration experiments and internal validations were conducted to ensure the updated OncoSim-Breast model aligned with observed data from the Canadian Cancer Registry.
Release date: 2026-05-20
3. Assessing obesity beyond body mass index: Integrating physiological and functional indicators of impairment in national health surveillance
Articles and reports: 82-003-X202600300001
Description: Body mass index (BMI) is commonly used to estimate obesity prevalence; however, reliance on BMI alone can lead to an incomplete understanding of obesity’s impact on health. In line with the 2025 recommendations of the Lancet Diabetes & Endocrinology Commission, this study used measured and self-reported data from the 2016 to 2019 Canadian Health Measures Survey to combine population-level measures of excess adiposity with indicators of physiological dysfunction and activity limitation across eight body system domains. Clinical and preclinical obesity were characterized by excess adiposity and progressive obesity-related impairment among Canadian adults.
Release date: 2026-03-18
4. The OncoSim-Cervix cancer microsimulation model: Unveiling roll-out strategies for human papillomavirus primary testing
Articles and reports: 82-003-X202501000002
Description: Globally, cervical cancer is one of the most common cancers, yet it is largely preventable. Switching methods for primary screening from cytology testing, via Pap test, to human papillomavirus (HPV) testing is a component of that prevention. OncoSim-Cervix, a Canadian cervical cancer microsimulation model, assesses the long-term effects of HPV vaccination and screening interventions. This study projects the impact of differing roll-out strategies for HPV primary testing for cervical cancer screening in Canada.
Release date: 2025-10-15
5. Metabolic syndrome in Canadian adults, 2007 to 2019
Articles and reports: 82-003-X202500900001
Description: Metabolic syndrome (MetS) is a clustering of multiple risk factors, including abdominal obesity (or high waist circumference), elevated triglycerides, low high-density lipoprotein cholesterol, high fasting blood glucose, and high blood pressure. MetS is an important contributor to cardiovascular disease and type 2 diabetes. Research indicates that MetS doubles the risk of cardiovascular disease and increases the risk of diabetes fivefold. Using the most recent nationally representative data from the Canadian Health Measures Survey, this study provides an updated prevalence of MetS and its components among Canadian adults aged 18 to 79 years by age group and sex.
Release date: 2025-09-17
6. Metabolic health and body mass index phenotypes in adults
Articles and reports: 82-003-X202500900002
Description: To better understand the interplay between adiposity and metabolic health, joint phenotypes have been used to categorize people as being metabolically healthy or metabolically unhealthy while having a body mass index indicative of obesity, overweight, or normal weight. This study examines the prevalence of these phenotypes in adults, the factors associated with them, and their relationship with adverse health outcomes.
Release date: 2025-09-17
7. Colorectal, cervical and breast cancer screening tests, 2024
Articles and reports: 82-625-X202500100002
Description: This fact sheet provides an overview of proportions of Canadians who have undergone tests commonly used for early detection of colorectal, cervical and breast cancer among people living in the ten provinces. It also examines differences by various groups, such as by sex, age, province, area type, racialized group, immigrant status, Indigenous group and disability status.
Release date: 2025-08-06
8. Comparing Canada's OncoSim-Breast model with the United States' Cancer Intervention and Surveillance Modeling Network (CISNET) breast cancer models
Articles and reports: 82-003-X202500600001
Description: The OncoSim-Breast model, developed by the Canadian Partnership Against Cancer and Statistics Canada, represents breast cancer-related events in the Canadian female population. This study aims to compare OncoSim-Breast microsimulation modelling results with recent results from the United States’ National Cancer Institute’s Cancer Intervention and Surveillance Modeling Network (CISNET) breast cancer models. The primary focus is on the impact of extending breast cancer screening to women aged 40 to 49.
Release date: 2025-06-18
9. Trends and inequalities in multimorbidity from 2001/2002 to 2019/2020: A population-based study in British Columbia
Articles and reports: 82-003-X202500300001
Description: Multimorbidity is the co-occurrence of two or more chronic diseases, and is a significant challenge for health care systems worldwide. There are limited data, particularly in a Canadian context, on multimorbidity prevalence and incidence. This study analyzed trends in the prevalence and incidence of multimorbidity and complex multimorbidity (five or more conditions) by sex, age, and neighbourhood income quintile in British Columbia. This study also identified the most prevalent disease combinations.
Release date: 2025-03-19
10. The health consequences of obesity history and weight fluctuations in adulthood
Articles and reports: 82-003-X202500200002
Description: The prevalence of Canadian adults with obesity has been steadily increasing over the past four decades. Nine percent of Canadian adults had obesity in 1981, 27.2% had obesity in 2018 and the most recent estimates from 2022 indicate that 30% of Canadian adults have obesity. The purpose of this study is to describe the obesity change pattern among Canadian adults aged 28 to 79 years and to examine associations between obesity history and health outcomes.
Release date: 2025-02-19

Data (0)

Data (0) (0 results)

No content available at this time.

Analysis (283)

Analysis (283) (0 to 10 of 283 results)

1. Geographic variation in female breast cancer incidence and mortality in Canada
Articles and reports: 82-003-X202600500001
Description: Previous research has found variability in cancer incidence and cancer-related outcomes according to place of residence. This study examined geographic variability in the incidence and mortality of breast cancer among females in Canada, using data from the 2021 Canadian Cancer Registry (breast cancer incidence) and the Canadian Vital Statistics – Death database (breast cancer mortality). Age-standardized incidence rates (ASIRs) and age-standardized mortality rates (ASMRs) per 100,000 females per year and their rate ratios were calculated, as well as age group-specific and age-standardized stage-specific incidence rates, and examined across provinces and territories, community sizes, and peer groups (i.e., clusters of health regions with similar socioeconomic and demographic characteristics).
Release date: 2026-05-20
2. Enhancing the OncoSim-Breast model using Canadian breast density information
Articles and reports: 82-003-X202600500002
Description: Breast cancer is the most commonly diagnosed cancer among women in Canada. Breast density substantially influences breast cancer risk and mammography performance. However, OncoSim-Breast, a Canadian microsimulation model representing breast cancer control, including cancer onset, screening, and survival, has not previously explicitly accounted for breast density. This study describes the incorporation of density-specific parameters—prevalence, relative risk of breast cancer, and digital mammography performance (sensitivity and specificity)—using data from five Canadian provinces, into the OncoSim-Breast model. Calibration experiments and internal validations were conducted to ensure the updated OncoSim-Breast model aligned with observed data from the Canadian Cancer Registry.
Release date: 2026-05-20
3. Assessing obesity beyond body mass index: Integrating physiological and functional indicators of impairment in national health surveillance
Articles and reports: 82-003-X202600300001
Description: Body mass index (BMI) is commonly used to estimate obesity prevalence; however, reliance on BMI alone can lead to an incomplete understanding of obesity’s impact on health. In line with the 2025 recommendations of the Lancet Diabetes & Endocrinology Commission, this study used measured and self-reported data from the 2016 to 2019 Canadian Health Measures Survey to combine population-level measures of excess adiposity with indicators of physiological dysfunction and activity limitation across eight body system domains. Clinical and preclinical obesity were characterized by excess adiposity and progressive obesity-related impairment among Canadian adults.
Release date: 2026-03-18
4. The OncoSim-Cervix cancer microsimulation model: Unveiling roll-out strategies for human papillomavirus primary testing
Articles and reports: 82-003-X202501000002
Description: Globally, cervical cancer is one of the most common cancers, yet it is largely preventable. Switching methods for primary screening from cytology testing, via Pap test, to human papillomavirus (HPV) testing is a component of that prevention. OncoSim-Cervix, a Canadian cervical cancer microsimulation model, assesses the long-term effects of HPV vaccination and screening interventions. This study projects the impact of differing roll-out strategies for HPV primary testing for cervical cancer screening in Canada.
Release date: 2025-10-15
5. Metabolic syndrome in Canadian adults, 2007 to 2019
Articles and reports: 82-003-X202500900001
Description: Metabolic syndrome (MetS) is a clustering of multiple risk factors, including abdominal obesity (or high waist circumference), elevated triglycerides, low high-density lipoprotein cholesterol, high fasting blood glucose, and high blood pressure. MetS is an important contributor to cardiovascular disease and type 2 diabetes. Research indicates that MetS doubles the risk of cardiovascular disease and increases the risk of diabetes fivefold. Using the most recent nationally representative data from the Canadian Health Measures Survey, this study provides an updated prevalence of MetS and its components among Canadian adults aged 18 to 79 years by age group and sex.
Release date: 2025-09-17
6. Metabolic health and body mass index phenotypes in adults
Articles and reports: 82-003-X202500900002
Description: To better understand the interplay between adiposity and metabolic health, joint phenotypes have been used to categorize people as being metabolically healthy or metabolically unhealthy while having a body mass index indicative of obesity, overweight, or normal weight. This study examines the prevalence of these phenotypes in adults, the factors associated with them, and their relationship with adverse health outcomes.
Release date: 2025-09-17
7. Colorectal, cervical and breast cancer screening tests, 2024
Articles and reports: 82-625-X202500100002
Description: This fact sheet provides an overview of proportions of Canadians who have undergone tests commonly used for early detection of colorectal, cervical and breast cancer among people living in the ten provinces. It also examines differences by various groups, such as by sex, age, province, area type, racialized group, immigrant status, Indigenous group and disability status.
Release date: 2025-08-06
8. Comparing Canada's OncoSim-Breast model with the United States' Cancer Intervention and Surveillance Modeling Network (CISNET) breast cancer models
Articles and reports: 82-003-X202500600001
Description: The OncoSim-Breast model, developed by the Canadian Partnership Against Cancer and Statistics Canada, represents breast cancer-related events in the Canadian female population. This study aims to compare OncoSim-Breast microsimulation modelling results with recent results from the United States’ National Cancer Institute’s Cancer Intervention and Surveillance Modeling Network (CISNET) breast cancer models. The primary focus is on the impact of extending breast cancer screening to women aged 40 to 49.
Release date: 2025-06-18
9. Trends and inequalities in multimorbidity from 2001/2002 to 2019/2020: A population-based study in British Columbia
Articles and reports: 82-003-X202500300001
Description: Multimorbidity is the co-occurrence of two or more chronic diseases, and is a significant challenge for health care systems worldwide. There are limited data, particularly in a Canadian context, on multimorbidity prevalence and incidence. This study analyzed trends in the prevalence and incidence of multimorbidity and complex multimorbidity (five or more conditions) by sex, age, and neighbourhood income quintile in British Columbia. This study also identified the most prevalent disease combinations.
Release date: 2025-03-19
10. The health consequences of obesity history and weight fluctuations in adulthood
Articles and reports: 82-003-X202500200002
Description: The prevalence of Canadian adults with obesity has been steadily increasing over the past four decades. Nine percent of Canadian adults had obesity in 1981, 27.2% had obesity in 2018 and the most recent estimates from 2022 indicate that 30% of Canadian adults have obesity. The purpose of this study is to describe the obesity change pattern among Canadian adults aged 28 to 79 years and to examine associations between obesity history and health outcomes.
Release date: 2025-02-19

Reference (0)

Reference (0) (0 results)

No content available at this time.

Date modified:: 2026-08-02